CLINICAL_TRIALS
trial_result
· 2020-09-16
Clinical Trial Update: Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis [Phase 3]
Summary
Phase 3 trial completion for RVL-1201 in blepharoptosis with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: RVL Pharmaceuticals, Inc. | Conditions: Blepharoptosis | Phase 3 | Status: COMPLETED | Results posted: 2020-09-16